Mckesson Medical-Surgical Inc. Corporate Office: Drug Recall
Recall #D-1040-2022 · 04/13/2022
Class II: Risk
Recall Details
- Recall Number
- D-1040-2022
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Mckesson Medical-Surgical Inc. Corporate Office
- Status
- Terminated
- Date Initiated
- 04/13/2022
- Location
- Richmond, VA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 57 pouches
Reason for Recall
cGMP deviations: Temperature abuse
Product Description
Ipratropium Bromide Inhalation Solution, 0.02%, 0.5 mg/2.5 mL, packaged in 25-count box (25 x 2.5 mL sterile unit-dose vials), Rx only, MFG: Nephron Pharma, NDC 0487-9801-25
Distribution Pattern
USA nationwide.
Other Recalls by Mckesson Medical-Surgical Inc. Corporate Office
- Class II: Risk 07/30/2025
- Class II: Risk 04/25/2025
- Class II: Risk 04/25/2025
- Class II: Risk 04/24/2025
- Class II: Risk 04/24/2025
View all recalls by Mckesson Medical-Surgical Inc. Corporate Office →
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.